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INTRODUCTION 
 
 
 
 
 
 
INTRODUCTION 
Heart failure is one of the leading causes of hospitalizations in both developed 
as well as developing nations.  
Regardless of the definition used, the prevalence of HF increases steeply with 
age, Prevalence is 1% between the ages of 50 and 59 years, progressively 
increasing to >10% over age of 80 years
1,2
.  
Heart Failure is generally described as a clinical syndrome associated with 
impaired left ventricular (LV) contractility and cavity dilation. 
―HF with preserved LVEF‖, or ―diastolic heart failure (DHF),‖ is thought to be 
due to abnormalities in the diastolic properties of the LV , Diastolic heart failure 
(DHF) is responsible for almost nearly 50% of all patients with heart failure & 
is frequently referred as heart failure with normal ejection fraction of left 
ventricle (HFNEF)
3
.  
This form of heart failure may result in long run heart failure with reduced 
ejection fraction. The recent advances in understanding of diastolic ECHO 
characters & biomarkers for heart failure resulted in modification of protocol 
for the diagnosis of HFNEF and recent update to diagnostic criteria. 
Although such hearts contract normally, relaxation (diastole) is abnormal. Such 
abnormality in cardiac relaxation is more pronounced during periods of exertion 
& exercise as cardiac output cannot adequately increase due to increased filling 
pressures of left ventricle.  
Due to this high filling pressure there are resultant pulmonary congestion, 
dyspnoea, and edema features that appear similar in presentation to regular 
systolic dysfunction. 
Unfortunately, unlike heart failure due to systolic dysfunction, diastolic heart 
failure has been studied in few clinical trials, so there is little evidence to guide 
the care of patients with this condition.  
Physiological principles used in the treatment of such patients include the 
control of blood pressure, heart rate, myocardial ischemia, and blood volume. 
Although diastolic dysfunction is thought to be the only mechanism responsible 
for the development of heart failure with a preserved ejection fraction, 
community based studies suggest that additional mechanisms such as increased 
vascular & ventricular stiffness may also be responsible. 
 
 
 
 
 
                                                                                                                                                                                         
 
  
 
 
 
AIM OF THE STUDY 
 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
1) To do an observational study analysing the  
a) Clinical presentation,  
b) Risk factor profile,  
c) Diagnostic evaluation with Echocardiograph correlation of Heart 
failure with normal/preserved ejection fraction. 
 
2) To understand the variability of several ECHO characteristics with 
increasing diastolic dysfunction. 
 
3) To find a relation between several anthropometry measurements & 
increasing diastolic dysfunction. 
 
 
 
 
 
  
 
 
 
REVIEW OF LITERATURE 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
Heart failure (HF) can be defined as the inability of the myocardium to sustain 
adequate cardiac output to maintain tissue perfusion and oxygenation 
requirements while maintaining normal filling pressures
1
.  
Three major mechanisms that are implicated in the patho-physiology of chronic 
heart failure
3
:  
a) Impaired myocardial contractility- ‗systolic dysfunction‘  
b) Inadequate or impaired filling of the cardiac chambers- ‗diastolic 
dysfunction‘.  
c) Nonphysiologic changes in cardiac volume, mass, and geometry- 
‗pathological remodelling‘. 
Patients with chronic HF can be divided into two broad categories, classified on 
the basis of characteristic changes in cardiovascular structure and function
26, 27
: 
a)  Systolic heart failure (SHF), which is characterized by abnormalities in 
systolic function (i.e., reduced left ventricular ejection fraction [LVEF]) 
often with progressive chamber dilation and eccentric remodeling.  
b) Diastolic heart failure (DHF), which is characterized by normal LV 
volume, concentric remodeling, normal LV chamber systolic properties, 
and abnormalities in diastolic function 
7,16,25,26,28,29
. 
SHF and DHF are distinct syndromes, not a continuous spectrum of disorders. 
Patients with SHF may have evidence of diastolic dysfunction, particularly 
during  periods of symptomatic decompensation 
45, 49, 50, 51
 
Framingham Criteria for Congestive Heart Failure
1 
Diagnosis of CHF requires the simultaneous presence of at least 2 major criteria 
or 1 major criterion in conjunction with 2 minor criteria. 
Major criteria: 
·        Paroxysmal nocturnal dyspnea 
·        Neck vein distention 
·        Rales 
·        Radiographic cardiomegaly (increasing heart size on chest radiography) 
·        Acute pulmonary edema 
·        S3 gallop 
·        Increased central venous pressure (>16 cm H2O at right atrium) 
·        Hepatojugular reflux 
·        Weight loss >4.5 kg in 5 days in response to treatment 
Minor criteria: 
·        Bilateral ankle edema 
·        Nocturnal cough 
·        Dyspnea on ordinary exertion 
·        Hepatomegaly 
·        Pleural effusion 
·        Decrease in vital capacity by one third from maximum recorded 
·        Tachycardia (heart rate>120 beats/min.) 
Minor criteria are acceptable only if they cannot be attributed to another 
medical condition (such as pulmonary hypertension, chronic lung disease, 
cirrhosis, ascites, or the nephrotic syndrome). 
The Framingham Heart Study criteria are 100% sensitive and 78% specific for 
identifying persons with definite congestive heart failure
1, 52
. 
Diastolic heart failure (DHF) is a clinical syndrome in which patients have 
symptoms and signs of HF, normal or near normal left ventricular (LV) 
ejection-fraction (EF), and evidence of diastolic dysfunction (eg, abnormal left 
ventricular filling and elevated filling pressures) 
4,6
  
This condition has been labelled diastolic heart failure (DHF) or "Heart failure 
with normal ejection fraction" (HFNEF) 
5
. In such patients, diastolic 
dysfunction is the underlying cause of the congestive failure
1, 6
.  
It is important to note that the ACC/AHA criteria for DHF do not require an 
echocardiographic diagnosis of DD. It has been argued that, since the 
echocardiographic characteristics of DD are potentially difficult to interpret and 
user-dependent, the simple syndrome of HF with preserved LVEF should be 
sufficient to establish the diagnosis of DHF
7
 
PREVALENCE AND DEMOGRAPHICS — 
The prevalence of diastolic heart failure increases with age
6
. This was illustrated 
in a review in which the estimated prevalence of diastolic heart failure among 
patients with HF was 15, 33, and 50 percent at ages less than 50, 50 to 70, and 
more than 70 years, respectively
1, 6, 8
.  
DHF is more common in women than men have diastolic heart failure 
8
. 
Among patients with normal ejection fraction, 79 percent were women, while 
among those with decreased ejection fraction, 49 percent were 
women
8
.Asymptomatic diastolic dysfunction is much more common than 
symptomatic disease
9
.  
 Patients with diastolic dysfunction
10
: 
a)  More likely to be older, female, and hypertensive10  
b) Less likely to have had a prior myocardial infarction10  
c) Less likely to be receiving an angiotensin converting enzyme inhibitor or 
angiotensin II receptor blocker
10
. 
d)  Lower in-hospital mortality (3 vs 4 %) but similar ICU and hospital 
length of stay
10
.  
ETIOLOGY —  
The major causes of DHF are the following
6
:  
a) Chronic hypertension with left ventricular hypertrophy (LVH)46 ; a 
hypertensive hypertrophic cardiomyopathy with LVEF above 75 percent 
has been described in elderly adults with HF
47
  
b) Hypertrophic cardiomyopathy (HCM)  
c) Aortic stenosis with a normal LVEF48 
d)  Coronary heart disease  
e) Restrictive cardiomyopathy, which can be idiopathic or caused by 
infiltrative disease 
 
 
 
 
Basic Physiology
31-39 
Phases of Diastole 
The timing of Diastole begins with the Aortic valve closure and terminates with 
mitral valve closure. Diastole is further divided into four phases 
1. Isovolumetric relaxation: This is the period of cardiac cycle between the 
end of LV systolic ejection (i.e. aortic valve closure) and the opening of 
the Mitral valve, during this phase the volume of LV is maintained 
constant while LV pressure keeps falling rapidly. This is the phase of 
rapid active LV relaxation, with a lower, variable contribution of elastic 
recoil of the contracted fibers 
2. LV rapid filling: This the period of cardiac cycle when the LV pressure 
falls below left atrial pressure and there is mitral valve opening. During 
this phase there is accelerated flow of blood into LV which reaches 
maximum velocity, directly related to magnitude of atrio-ventricular 
pressure. This phase reflect the complex interaction between LV active 
relaxation and visco-elastic properties of the LV(i.e. compliance) 
3. Diastasis: This is the phase of continued blood flow into the LV, even 
after left atrial and LV pressures are almost equal, with left atrium 
representing a passive conduit, and the amount of blood flow depending 
on LV pressure (i.e. diastolic compliance) 
4. Atrial systole: This phase of cardiac cycle is the period of left atrial 
contractionand ends with mitral valve closure. LV compliance, 
pericardial resistance, atrial force, artio-ventricular synchronicity have an 
influence on this phase. 
Isovolumic relaxation (time between aortic valve closure and mitral valve 
opening) and three phases of left ventricular filling: rapid early filling, diastasis 
and late filling, from atrial contraction 
                       
 
      
Figure 1
30 
Electrical, pressure, flow (Doppler), tissue (Doppler), and volume events during 
systole and diastole. IVR= isovolumic relaxation; LV=left ventricle; 
MVVC=mitral valve closed; AVO=aortic valve open; AVC=aortic valve 
closed; MVO=mitral valve open; TDI=tissue Doppler. (Modified from Jaski 
BE. Basics of Heart Failure: A Problem Solving Approach. Boston: Kluwer 
Academic Publishers, 2000)
30 
                          
Systolic versus diastolic HF 
6, 41-44
 
        
Figure 2
40
 
Systolic versus Diastolic HF 
3, 45
 
                       
Figure 3 
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Figure 4 
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Systolic versus Diastolic HF 
 
 
Figure 5: Left Ventricular Pressure–Volume Loops in Systolic and 
Diastolic Dysfunction
25
. 
In systolic dysfunction, left ventricular contractility is depressed, and the 
end-systolic pressure–volume line is displaced downward and to the right 
(Panel A, black arrow); as a result, there is a diminished capacity to eject 
blood into the high-pressure aorta. In diastolic dysfunction, the diastolic 
pressure–volume line is displaced upward and to the left (Panel C, black 
arrow); there is diminished capacity to fill at low left-atrial pressures. In 
systolic dysfunction, the ejection fraction is depressed, and the end-diastolic 
pressure is normal (Panel A, open arrow); in diastolic dysfunction, the 
ejection fraction is normal and the end-diastolic pressure is elevated (Panel 
C, open arrow) 
25
. 
Systolic versus Diastolic HF 
Characteristics of Diastolic Heart Failure as Compared with 
Those of Systolic Heart Failure 
19-24
 
 
            
Table 1 
    
 
 
 
 
Cellular mechanisms of diastolic dysfunction 
Diastolic dysfunction is caused by one or more of the following abnormalities in 
cardiac structure:  
a) Hypertrophy 
b) Fibrosis  
c) Infiltrative diseases  
d) Pericardial constriction  
e) Myocardial edema 
Functional cellular abnormalities of myocyte relaxation can also cause diastolic 
dysfunction, which is reversible and transient 
6
. Causes of impaired myocyte 
relaxation include: 
a) Ischemia and/or hypoxia  
b) Cellular calcium overload and/or ATP depletion  
c) Certain cardiovascular drugs, eg, digitalis  
d) The hypertrophy process itself which alters the contractile and metabolic 
phenotype. 
There is a highly positive correlation between end-diastolic calcium levels and 
diastolic relaxation abnormalities.            
The duration of diastole is prolonged in most models of congestive heart failure, 
a change that correlates with a prolongation of the intracellular calcium 
transient 
18
.  
In hypertrophic cardiomyopathy, systolic function is normal or hyperdynamic, 
but diastolic relaxation may become so abnormally slow that complete 
relaxation between contractions is prevented. At rapid heart rates, this can 
produce elevated end-diastolic calcium levels and mechanical dysfunction 
resulting from fusion of the prolonged calcium transients and contractions. 
Diastolic dysfunction in DHF/HFNEF 
In DHF, abnormalities in diastolic function form the dominant patho-
physiologic basis for the development of HF. 
The major abnormalities in LV diastolic function that contribute to the 
development of DHF include 
7, 16, 17
:  
a) Slowed, delayed and incomplete myocardial relaxation 
b) Impaired rate and extent of LV filling  
c) Shift of filling from early to late diastole  
d) Decreased early diastolic suction/recoil  
e) Increased LA pressure during the early filling 
f) Increased passive stiffness  
g) decreased distensibility of the LV Impaired ability to augment cardiac 
output during exercise  
h) Impaired ability to augment relaxation during exercise  
i) Inability to utilize the Frank-Starling mechanism during exercise  
j) Increased diastolic LV, LA, pulmonary venous pressure at rest and/or 
during exercise. 
Decompensated DHF may be caused by both cardiovascular and non-
cardiovascular factors (and "triggers" Uncontrolled hypertension Increased salt 
and   water intake and/or retention Tachyarrhythmias, CKD, Anemia).  
Diagnosis of Diastolic Heart Failure/HFNEF 
Three obligatory conditions need to be satisfied for the diagnosis of HFNEF:  
a) Presence of signs or symptoms of congestive heart failure;  
b) Presence of normal or mildly abnormal LV systolic function, and  
c) Evidence of diastolic LV dysfunction. 
Following diagnostic criteria proposed for Diastolic Dysfunction: 
a) Vasan and Levy Criteria15 
b) Zile Criteria4 
c) European Criteria 
Vasan and Levy Criteria 
15
 
Vasan and Levy stated that the diagnosis of CHF is clinical and should not be 
made on the basis of LV EF,Q and they indicated that the requirement of a 
normal EF for the diagnosis of heart failure would inevitably lead to an 
underestimation of the prevalence of heart failure. 
They then developed criteria for definite, probable, and possible diastolic heart 
failure:  
‘Definite’ diastolic heart failure required definitive evidence of heart failure, 
normal or mildly abnormal LV EF, and evidence of abnormal LV relaxation, 
filling, diastolic distensibility, or diastolic stiffness (they require cardiac 
catheterization for the assessment of diastolic function)
 15
. 
Vasan and Levy make the diagnosis of ‘probable’ diastolic heart failure if 
catheterization evidence of diastolic dysfunction is not available and ‘possible’ 
diastolic heart failure if the EF was not measured near the time of the patient‘s 
presentation with heart failure (i.e. within 72 hours of the heart failure event)
 15
. 
A diagnosis of possible diastolic heart failure may be ‗upgraded‘ to probable if 
the setting is typical for diastolic dysfunction
15
. 
 
 
Vasan and Levy Criteria for Diastolic Heart Failure 
15
 
 
Table 2: Criteria for ‘Definite’ DHF 15 
 
 
Table 3: Criteria for ‘Probable’ DHF 15 
 
 
Table 4: Criteria for ‘Possible’ DHF 15 
 
 
Table 5: Criteria for diastolic HF according to the European Society of 
Cardiology 
14
 
 
 
Table 6: Doppler echocardiographic patterns of current echocardiographic 
tools in relation to the grading of LV diastolic dysfunction 
13
 
 
Zile Criteria 
4
 
Recognizing the difficulties inherent in the assessment of the diastolic 
properties of the heart, Zile et al tested the hypothesis that measurements of the 
LV relaxation and passive stiffness were not necessary to make the diagnosis of 
diastolic heart failure 4. 
  
Doppler Criteria for Classification of Diastolic Function
11, 12
 
 
 
Figure 6 
 
  
 
 
 
MATERIALS AND METHODS OF THE STUDY 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS OF THE STUDY 
PATIENT SELECTION: 
The present study included heart failure patients admitted to Government 
Stanley Hospital Medical Departments; a consecutive series of 52 heart failure 
patients admitted in the Department of Medicine, Stanley Medical College and 
Government Stanley hospital, during the period of 6 months from July 1
st
 2010 
to Dec 30
th
 2010. Patients selected fulfilled the Framingham‘s criteria for heart 
failure & Normal/preserved ejection fraction. 
INCLUSION CRITERIA: 
1) Symptoms and signs of HF (Framingham criteria),  
2) LV EJECTION FRACTION   > 45-50%, and 
3) Ability to rule out: Mitral stenosis, Mitral regurgitation, pericardial disease, 
and non cardiac causes of dyspnoea, oedema and fatigue. 
EXCLUSION CRITERIA: 
1) Heart failure patients with EF<45% any time during their clinical course 
2) Patients who underwent cardiac surgeries (CABG, valve repair, etc)  
3) Chest wall injuries (blunt/penetrating) 
4) Age<14yrs   
  
 
 
 
PATIENT EVALUATION 
 
 
 
 
 
 
 
 
 
 
PATIENT EVALUATION 
All of the 52 patients included in the study are thoroughly evaluated clinically 
with particular focus on identifying the clinical signs & symptoms of the heart 
failure. Patients are further investigated to identify several known risk factors 
for heart failure & increased mortality related to cardiac illness. Patients 
underwent Doppler echocardiographic evaluation within 24 hrs of presentation, 
chest x-ray; USG abdomen & pelvis were also done. 
Patients age, sex, socioeconomic status, occupation were noted. Patient 
symptoms are further questioned for duration, onset (sudden/insidious), 
aggravating/precipitating factors (exertion/emotional upset/others), relieving 
factors (rest/posture/drugs), NYHA Class for dyspnea & presence of 
PND/orthopnoea/platypnea. 
Patient clinical examination particularly focused on identifying several 
indicators of heart failure (Neck vein distention, Rales, S3 gallop, S4), including 
the vital signs & cardiovascular system. Respiratory, abdominal, CNS 
examinations were done & relevant findings noted. 
Patients are subjected to several biochemical investigations like fasting & post- 
prandial blood glucose, fasting lipid profile, renal function tests, and complete 
hemogram. 
Several key elements evaluated in the study are defined as followed: 
1) Heart failure : Framingham Criteria for Congestive Heart Failure 
2) Obesity : Based on BMI 
3) Dyslipidemia: Hypertriglyceridemia: Triglycerides ≥150 mg/dL;  Low 
HDL cholesterol: <40 mg/dL and <50 mg/dL, for men & women 
respectively; total cholesterol >250mg/dl; high LDL cholesterol 
>160mg/dl;  or specific medication 
4) Metabolic syndrome: NCEP:ATPIII 2001& IDF Criteria for Central 
Adiposity 
5) Grade of Diastolic dysfunction: based on European Society of Cardiology 
2007 criteria. 
6) Cigarette smoking: Smoking Index 
7) Diabetes mellitus: FPG>126mg/dl; PPPG>200mg/dl; HBA1c >6.5%. 
Following anthropometric measurements are also taken as part of routine 
examination, weight, Height, waist circumference, Hip circumference. 
Following entities are calculated, BMI, BSA, W/H ratio. All measurements are 
taken by same equipment & noted in metric systems. 
Echocardiography is done for all the patients within 24 hrs of onset of 
presentation. Both 2D and color Doppler echocardiography was done by a 
single experienced cardiologist. Following ECHO characters are essentially 
noted:  
a) Ejection fraction. 
b) E wave velocity (m/sec) at mitral valve. 
c) A wave velocity (m/sec) at mitral valve. 
d) E/A ratio. 
e) Deceleration time (msec). 
All patients satisfied the inclusion & exclusion criteria necessary for selection 
under study. 
 
STUDY DESIGN  
This study is a cross sectional observational study. 
 
 
 
 
 
  
 
 
 
OBSERVATIONS AND STATISTICAL ANALYSIS 
 
 
 
 
 
 
 
 
 
 
OBSERVATIONS AND STATISTICAL ANALYSIS 
The population of 52 patients included in the study belong to a unified group 
satisfying all the inclusion criteria & exclusion criteria. They are the patients 
with Heart failure with normal ejection fraction ‗HFNEF‘. Each patient 
underwent clinical examination to identify features of heart failure; biochemical 
investigations to identify the cardiac risk factors; 2D ECHO & Doppler ECHO 
study is quantify few specific Diastolic functional characteristics. 
STATISTICAL METHODS 
All continuous variables were assumed to be normally distributed and are 
reported as arithmetic mean with their standard deviation. The 95% confidence 
intervals are also reported where clinically applicable. The strength of the linear 
relationship between two variables is analyzed as Correlation coefficient 
(spearman). The Fisher‘s Exact test (2x3 Fisher's exact test calculator) 53 was 
used to compare and analyze the data. The null hypothesis was rejected at the 
95% confidence interval, considering a probability value of P < 0.05 as 
statistically significant & probability value of P
 
<0.0001 as extremely 
significant. 
Fisher‘s Exact test done using 2x3 Fisher's exact test calculator, Joosse SA. 
2011 Fisher's exact test, available from http://in-
silico.net/statistics/fisher_exact_test. 
  
 
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
RESULTS 
A total of 52 patients who consulted to the medical department Govt Stanley 
Hospital & who satisfied the inclusion as well exclusion criteria were enrolled 
for this study. Among the 52 patients 22 were males & 30 were females, with an 
average age of 62.54 (SD 13.27), the youngest among the lot being 40yr & the 
oldest being 88yr 
Table 1: Details of age 
Parameters Average SD Min Max 
Age (Yrs) 62.54 13.27 40 88 
The average age of the patients enrolled in the study was 62.54 years. 
                        
Table 2: Details of age according to the gender 
Anthro
pometr
y 
Gender Gran
d 
total 
Male Female 
N Mean ± SD Min Max N Mean ± SD Min Max 
Age 22 
57.09 ± 
12.74 
43 80 30 66.53 ± 12.36 40 88 52 
 
 
 
 
 
 
 
SEXWISE DISTRIBUTION OF PATIENTS IN THE STUDY 
TABLE -3 
Age group Number Percentage 
Male 22 25 
Female 30 26.92 
 
Out of 52 patients, 42.31% were male whereas, 57.69% were female. Thus 
majority of the patients were female. 
      
AGE WISE DISTRIBUTION OF PATIENTS IN STUDY GROUP 
Table 4: Age wise distribution of the patients. 
 
Age 
Gender 
Grand 
total 
Male Female 
N % N % 
40-50 10 76.92 3 23.08 13 
51-60 6 42.86 8 57.14 14 
61-70 1 9.09 10 90.90 11 
71-80 5 55.56 4 44.44 9 
80-90 0 0 5 100 5 
Grand Total 22 42.31 30 57.69 52 
 In studied group, majority of the cases were from the age group of 40-60 years. 
21.15% cases were from the age group 61-70 years. 9 cases were seen in 71-80 
years age group whereas, 5 cases were from the age group of 81-90 years 
Figure 1 
        
Figure 2 
        
42%(22)
58%(30)
Sex Distribution in Study Population
Male
Female
40-50 51-60 61-70 71-80 81-90
Male 10 6 1 5 0
Female 3 8 10 4 5
0
2
4
6
8
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12
AGE WISE DISTRIBUTION OF PATIENTS 
IN STUDY GROUP 
Table 5: Distribution based on the anthropometry according to the gender 
Anthropome
try 
Gender Gran
d 
total 
Male Female 
N Mean ± SD Min Max N Mean ± SD Min Max 
Height 22 
165.90 ± 
8.45 
150 178 30 
149.83 ± 
5.10 
142 165 52 
Weight 22 
81.36 ± 
20.22 
46 110 30 62 ± 8.87 46 81 52 
BMI 22 29.09 ± 4.95 20.44 36.75 30 
27.52 ± 
3.02 
21 
34.2
4 
52 
BAS 22 1.88 ± 0.27 1.38 2.22 30 1.56 ± 0.12 1.34 1.88 52 
Waist in cm 22 
98.68 ± 
13.78 
78 124 30 
86.83 ± 
7.31 
68 102 52 
Hip in cm 22 
101.14 ± 
15.34 
81 134 30 
92.03 ± 
8.47 
73 106 52 
W/H ratio 22 0.97 ± 0.04 0.91 1.05 30 0.94 ± 0.05 0.82 1.09 52 
 
     Table 6: Correlation of BMI with grade of DD. 
Grade of diastolic 
dysfunction 
BMI 
Waist to Hip 
ratio 
Mean ±Sd Mean ±Sd 
1 27.13±4.30 0.94±0.05 
2 27.79±3.57 0.96±0.04 
3 31.43±3.02 0.98±0.06 
Grand Total 28.19±3.99 0.95±0.05 
 
Table 7: Comparison of W/H ratio as per the grade of diastolic dysfunction 
W/H ratio Grade of diastolic dysfunction 
 
Grand 
Total 
1 2 3 
<0.9 
4 1 - 5 
(22.22%) (4%)  (9.61%) 
0.9 to 1 
12 21 5 38 
(66.67%) (84%) (55.56%) (73.07%) 
>1 
2 3 4 9 
(11.11%) (12%) (44.44%) (17.31%) 
Grand Total 18 25 9 52 
 
 
Table 8: Comparison of BMI as per the grade of diastolic dysfunction 
 
BMI group 
Grade of diastolic dysfunction  
Grand 
Total 1 2 3 
<18. 5 kg/m2 
- - - 0 
    
≥ 18.5 to 24.9 kg/m2 
7 7 
 
14 
(38.89%) (28%)  (26.92%) 
≥ 25.0 to 29.9 kg/m2 5 9 2 16 
(27.78%) (36%) (22.22%) (30.77%) 
30.0 to 34.9 kg/m2 
5 9 6 20 
(27.78%) (36%) (66.67%) (38.46%) 
35.0 to 39.9 kg/m2 
1 
 
1 2 
(5.56%)  (11.11%) (3.85%) 
≥ 40 kg/m2. 
- - - 0 
0    
Grand Total 18 25 9 52 
 
 
 
 
Table 9: Correlation of BMI and W/H ratio as per the grade of diastolic 
dysfunction 
 
Parameter Parameter 
Correlation 
coefficient 
(spearman’s) 
P value 
Diastolic 
dysfunction 
BMI 0.291 0.036 
W/H ratio 0.348 0.012 
 
P value is significant if <0.05 
 
Table 10: Details of risk factors 
 
Risk factors 
Number of subjects with the risk factors (n=52) 
N % 
Diabetes 32 61.54 
Dyslipidemia 35 67.31 
Hypertension 48 92.30 
Metabolic syndrome 40 76.92 
Obesity 22 42.31 
Alcohol 16 30.77 
Smoking 16 30.77 
 
Hypertension was the most common risk factor reported in the study in 94.23% 
of patients followed by Dyslipidemia in 67.31% cases, Diabetes was seen in 
61.54% cases, metabolic syndrome was seen in 76.92% cases. Obesity, smoking 
& alcohol were seen was seen in 42.31%, 30.77%, 30.77% cases respectively. 
                       
Table 11: Details of presenting complaints 
 
Presenting complaints 
Number of subjects with the risk factors (n=52) 
N % 
Dyspnea 47 90.38 
Edema 22 42.31 
Fatigue 47 90.38 
PND 29 55.77 
 
Dyspnea and fatigue was present in 90.38% of cases, PND in 55.77% cases and 
edema in 42.31% cases. 
Table 12: Details of physical examination 
 
Physical examination Average SD Min Max 
Pulse rate /min 83.21 8.31 64 102 
Systolic BP (mm of hg) 173.27 24.17 130 230 
Diastolic BP (mm of 
hg) 
107.81 11.35 84 130 
Respiratory rate 
(cycles/min) 
21.10 2.08 18 26 
 
The mean pulse rate of the patients was 83.21 ± 8.31/min. Mean systolic blood 
pressure of the patients recorded was 173.27 ± 24.17 mm of Hg. Average 
diastolic pressure of the patients was 107.81±11.35mm of Hg, whereas the 
respiratory rate of the patients studied was 21.10 ± 2.08 cycles /min. 
 
Table 13: Details of physical examination according to the gender. 
 
Physical 
examination 
Gender 
Gran
d 
Total  
Male Female 
N Mean ± SD Min 
Ma
x 
N Mean ± SD Min 
Ma
x 
Pulse rate 
bpm 
22 
84.36 ± 
7.13 
74 102 30 82.37 ± 9.10 64 98 52 
Systolic 22 178 ± 28.33 130 230 30 
169.8 ± 
20.42 
130 220 52 
Diastolic 22 
108.18 
±12.16 
84 130 30 
107.53 ± 
10.92 
84 124 52 
Respiratory 
rate cycle/min 
22 
21.14 ± 
2.43 
18 26 30 21.07 ± 1.82 18 25 52 
 
Table 14: Echo characteristics according to the gender 
Echo 
characteristics 
Gender 
Male Female 
Number Mean SD Min Max Number Mean SD Min Max 
E wave m/s 
22.00 0.90 0.28 0.50 1.50 30.00 0.87 0.32 0.32 1.56 
A wave m/s 
22.00 0.87 0.15 0.54 1.10 30.00 0.85 0.16 0.49 1.10 
E/A ratio 
22.00 1.10 0.48 0.55 2.14 30.00 1.03 0.38 0.51 2.10 
DT ms 
22.00 147.91 33.17 80.00 198.00 30.00 158.27 30.50 83.00 210.00 
EF % 
22.00 51.59 2.67 46.00 56.00 30.00 51.77 2.53 46.00 56.00 
LVEDV ml 
22.00 104.09 23.22 80.00 196.00 30.00 96.57 14.50 68.00 121.00 
LVEDVI ml/m2 
22.00 56.71 17.54 37.20 124.84 30.00 62.38 11.29 41.21 84.61 
Grade of 
diastolic 
dysfunction 
22.00 1.86 0.77 1.00 3.00 30.00 1.80 0.66 1.00 3.00 
 
Table 15: Details of echo characteristics. 
Echo 
characteristics 
Average SD Min Max 
A wave (m/s) 0.86 0.15 0.49 1.1 
E/A ratio 1.06 0.42 0.51 2.14 
DT(ms) 153.88 31.76 80 210 
 
Average of E wave in the study was 0.93 m/sec, A wave in the study was 0.86 
m/s. Mean E/A ratio reported was 1.06. Average DT (ms) was 153.88. 
Average Ejection fraction of the study group is calculated as 51.30%. Diastolic 
dysfunction was found in all of 52 patients included in the study group, Grade 1 
Diastolic dysfunction present in 18 patients, Grade 2 Diastolic dysfunction 
present in 25 patents, Grade 3 Diastolic dysfunction present in 9 patients. 
Table 16: Details of E wave as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Average E 
wave m/s 
StdDev  E wave 
m/s 
1 0.57 0.11 
2 0.98 0.21 
3 1.23 0.20 
Grand Total 0.88 0.30 
 
Table 17: Details of A wave as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Average A wave 
m/s 
Std Dev A wave 
m/s 
1 0.88 0.14 
2 0.89 0.13 
3 0.71 0.16 
Grand Total 0.86 0.15 
 
Table 18: Details of E/A ratio as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Average E/A 
ratio 
Std Dev  E/A 
ratio 
1 0.65 0.07 
2 1.10 0.20 
3 1.76 0.25 
Grand Total 1.06 0.42 
 
Table 19: Details of DT as per the grade of diastolic dysfunction 
Grade of diastolic  
dysfunction 
Average of 
DT ms 
StdDev of DT 
ms 
1 166.83 25.75 
2 163.36 16.64 
3 101.67 21.56 
Grand Total 153.88 31.76 
 
Table 20: Details of hypertension as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Number of patients with 
Hypertension P value 
N % 
Grade 1(n=18) 14 77.77 
0.0195 
Grade 2(n=25) 25 100.00 
Grade 3(n=9) 9 100.00 
Grand Total 48 94.23 
Fisher‘s exact test is applied. P value is significant if < 0.05  
In grade I diastolic dysfunction, all 14 patients had hypertension. In grade II 
diastolic dysfunction, 100% patients had hypertension. And in patients with 
grade III diastolic dysfunction, all 9 patients had hypertension. In our study, all 
three groups were comparable.  
Table 21: Details of Dyslipidemia as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Number of patients with 
Dyslipidemia P value 
N % 
Grade 1(n=18) 12 66.67 
0.0447 
Grade 2(n=25) 14 53.85 
Grade 3(n=9) 9 100.00 
Grand Total 35 67.31 
Fisher‘s exact test is applied. P value is significant if < 0.05  
In grade I diastolic dysfunction, 66.67% patients had dyslipidemia. In grade II 
diastolic dysfunction, 53.85% patients had dyslipidemia, whereas in grade III 
diastolic dysfunction, all 9 patients had dyslipidemia. Statistically all three 
groups were comparable. 
Table 22: Details of obesity as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Number of patients with 
obesity P value 
N % 
Grade 1(n=18) 6 33.33 
0.0437 
Grade 2(n=25) 9 34.62 
Grade 3(n=9) 7 77.78 
Grand Total 22 42.31 
Fisher‘s exact test is applied. P value is significant if < 0.05  
In our study, 18 patients had grade I diastolic dysfunction, out of which 33.33 % 
patients were obese. 25 patients had grade II diastolic dysfunction, out of which 
34.62% patients were found to be obese. Whereas, 9 patients had grade III 
diastolic dysfunction of which 77.78% patients were found obese. All three 
groups were comparable in the study. 
Table 23: Details of diabetes as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Number of patients with 
diabetes P value 
N % 
Grade 1(n=18) 13 72.22 
0.3438 
Grade 2(n=25) 15 57.69 
Grade 3(n=9) 4 44.44 
Grand Total 32 61.54 
Fisher‘s exact test is applied. P value is significant if < 0.05  
 
Table 24: Details of metabolic syndrome as per the grade of diastolic 
dysfunction 
Grade of diastolic 
dysfunction 
Number of patients with 
Metabolic syndrome P value 
N % 
Grade 1(n=18) 15 83.33 
0.0728 
Grade 2(n=25) 16 61.54 
Grade 3(n=9) 9 100.00 
Grand Total 40 76.92 
Fisher‘s exact test is applied. P value is significant if < 0.05  
 
 
Table 25: Details of smoking & alcohol as per the grade of diastolic 
dysfunction 
 
Grade of diastolic 
dysfunction 
Number of patients with 
smoking P value 
N % 
Grade 1(n=18) 5 27.78 
0.941 
Grade 2(n=25) 8 30.77 
Grade 3(n=9) 3 33.33 
Grand Total 16 30.77 
Fisher‘s exact test is applied. P value is significant if < 0.05  
Figure 3 
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 Table 26: Details of S4 as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Number of patients with S4 
P value 
N % 
Grade 1(n=18) 4 22.22 
<0.0001 
Grade 2(n=25) 21 84 
Grade 3(n=9) 9 100 
Grand Total 34 65.38 
Fisher‘s exact test is applied. P value is significant if < 0.05  
Table 27: Details of S3 as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Number of patients with S3 
P value 
N % 
Grade 1(n=18) 7 38.89 
0.674 
Grade 2(n=25) 10 38.46 
Grade 3(n=9) 5 55.56 
Grand Total 22 42.31 
Fisher‘s exact test is applied. P value is significant if < 0.05  
 
Table 28: Details of crepts as per the grade of diastolic dysfunction 
Grade of diastolic 
dysfunction 
Number of patients Crepts 
P value 
N % 
Grade 1(n=18) 16 88.89 
0.435 
Grade 2(n=25) 21 80.77 
Grade 3(n=9) 9 100.00 
Grand Total 46 88.46 
Fisher‘s exact test is applied. P value is significant if < 0.05. 
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DISCUSSION 
This study conducted at Govt. Stanley Hospital with an aim to identify the 
clinical profile, risk factors, and echocardiographic characteristics of the 
patients with heart failure with normal ejection fraction. This is a cross-sectional 
observation study aimed at population consulting at Medical Departments of 
Govt Stanley hospital. 
Following passages will describe & discuss the study findings in comparison 
with standard data & reviews available for Heart failure with normal ejection 
fraction (HFNEF) under several sub-headings: 
AGE & SEX 
The average age of the patients enrolled in the study was 62.54 years. In studied 
group, majority of the cases were from the age group of >50yrs, 14 cases 
(26.92%) were from the age group 50-60 years. 21.15% cases were from the age 
group 61-70 years. 9 cases (17.31%) were seen in 71-80 years age group 
whereas, 5 cases (9.62) were from the age group of 81-90 years. Overall 75% of 
patients included in the study group above 50 years. 
Out of 52 patients, 42.31% were male whereas, 57.69% were female. Thus 
majority of the patients were female. 
This reaffirms the findings from several studies
3, 5, 8
 that the patients with 
HFNEF are more likely to be older and women. 
Our attempts to identify the relation between increasing age & grade of diastolic 
dysfunction has not resulted in statistical significant results with average age of 
patients with Grade 1 diastolic dysfunction is 59 years; Grade 2 diastolic 
dysfunction 61.48 years; Grade 3 diastolic dysfunction 61.05 years. 
Haass M et al
53 
in their study(The I-PRESERVE Trial) concluded that in the 
usual patients with HFpEF, there were significant differences in the baseline 
characteristics with females showing overall better prognosis than males, this 
may however may be influenced by significant reduced risk of non-HF-related 
outcomes in females. There were significant differences in independent 
predictors of all- cause hospitalizations and mortality, with obesity, diabetes and 
CKD being most prominent in females 
Gottdiener JS, et al
55
 in their study the relationship between left ventricular 
systolic function and outcome of congestive heart failure in elderly persons. 
They concluded that there is higher prevalence of HFpEF among the elderly and 
mortality is higher among such individuals. 
Owan TE et al
3
 studied the trends in the prevalence and outcome of HFpEF. 
They concluded that there was significant trend towards increased proportions 
among heart failure patients with normal ejection fraction over the past 15 years 
and there was however same mortality rate there by emphasizing  the 
importance of this growing public health problem 
RISK FACTORS 
This study is a cross sectional observation study & all the patients include 
belonged to a unified group with Heart failure with Normal ejection fraction. 
We compared the risk factor profile of patients belonging to different grade of 
diastolic dysfunction (Grade 1, 2 & 3). 
Overall Hypertension was the most common risk factor reported in the study in 
94.23% of patients followed by Dyslipidemia in 67.31% cases, Diabetes was 
seen in 61.54% cases, metabolic syndrome was seen in 76.92% cases. Obesity, 
smoking & alcohol were seen was seen in 42.31%, 30.77% cases respectively. 
In grade I diastolic dysfunction, 14 patients (77%) had hypertension. In grade II 
diastolic dysfunction, 100% patients had hypertension. And in patients with 
grade III diastolic dysfunction, all 9 patients had hypertension. This was 
statistically significant (p=0.0195)  
In grade I diastolic dysfunction, 66.67% patients had dyslipidemia. In grade II 
diastolic dysfunction, 53.85% patients had dyslipidemia, whereas in grade III 
diastolic dysfunction, all 9 patients had dyslipidemia, this association was also 
significant (p=0.0447) 
In our study, 18 patients had grade I diastolic dysfunction, out of which 33.33 % 
patients were obese. 25 patients had grade II diastolic dysfunction, out of which 
34.62% patients were found to be obese. Whereas, 9 patients had grade III 
diastolic dysfunction of which 77.78% patients were found obese, this 
association was also statistically significant (p=0.0437). 
We found no statistically association with Diabetes, smoking & alcohol & 
increasing Grade of Diastolic dysfunction. 
This reaffirms the findings from several studies
3, 5, 8
 that the patients with 
HFNEF are more likely to be older, women & hypertensive, in addition we 
found statistically significant association with hypertension, dyslipidemia & 
obesity with increasing Grade of diastolic dysfunction. 
Toshihiko G et al
54
 studied hemodynamic indices especially the augmentation 
index  Alx, which shows the detrimental influence of arterial reflection wave 
from the lower body on LV diastolic function. They assessed the gender 
difference in these indices. The study revealed that there were no significant 
differences with age, heart rate, mean blood pressure, or indices of Diabetes and 
Dyslipidemia among males and females. There were no significant differences 
noted with LVEF or LV end diastolic pressures. Women showed significantly 
greater Alx values in comparison to men and there was significant correlation 
between plasma BNP values and Alx. There were also significantly higher BNP 
values, among females. They concluded that a combination of higher AIx and 
shorter height that is observed in women with shorter height may be one of the 
causes of the increased prevalence of HFpEF in women 
PRESNTING SYMPTOMS 
Dyspnea and fatigue was present in 90.38% of cases, PND in 55.77% cases and 
edema in 42.31% cases. 
ANTHROPOMETRY 
Average height of the patients was 156.63 ± 10.42 cm. Average weights of the 
patients was 70.19 ± 17.51 kg. Average BMI recorded were 28.19 ± 3.99 kg/m
2
. 
Average BSA was 1.70 ± 0.26. Average height, weight, BMI, BSA for male 
patients was 165.90 ± 8.45, 81.36 ± 20.22, 29.09 ± 4.95 & 1.88 ± 0.27 
respectively. Average height, weight, BMI, BSA for female patients was 149.83 
± 5.10, 62 ± 8.87, 27.52 ± 3.02 &1.56 ± 0.12 respectively. 
Mean waist of the patients recorded was 91.85 ± 11.98 cms, average hip 
circumference of the studied group was 95.88 ± 12.58 cm and the waist to hip 
ratio noted was 0.95 ± 0.05. 
We found statistically significant association with increasing BMI (p=0.036) & 
W/H ratio (p=0.012) with increasing Grade of Diastolic dysfunction. 
PHYSICAL FINDINGS 
The mean pulse rate of the patients was 83.21 ± 8.31/min. Mean systolic blood 
pressure of the patients recorded was 173.27 ± 24.17 mm of Hg. Average 
diastolic pressure of the patients was 107.81±11.35mm of Hg, whereas the 
respiratory rate of the patients studied was 21.10 ± 2.08 cycles /min. 
In grade I diastolic dysfunction, S4 wave was seen in 22.22% patients. In grade 
II diastolic dysfunction, S4 wave was seen in 84% patients, whereas in patients 
with grade III diastolic dysfunction, S4 wave was seen in 100% cases. This 
association was found statistically extremely significant (p<0.0001) for 
increasing Grade of Diastolic dysfunction. 
We found no statistical significance for presence of S3 & crepitations with 
increasing Grade of Diastolic dysfunction. 
ECHO CHARCTERISTICS  
For Grade 1 DD the average E wave is 0.57±0.11 m/s, A wave is 0.88±0.14 m/s, 
mean E/A ratio 0.65±0.07, Deceleration time is 166.83±25.75 ms. 
For Grade 2 DD the average E wave is 0.98±0.21 m/s, A wave is 0.89±0.13 m/s, 
mean E/A ratio 1.10±0.20, Deceleration time is 163.36±16.64 ms. 
For Grade 3 DD the average E wave is 1.23±0.21 m/s, A wave is 0.71±0.16 m/s, 
mean E/A ratio 1.76±0.25, Deceleration time is 101.67±21.56 ms 
Overall Average of A wave in the study was 0.86 m/s. Mean E/A ratio reported 
was 1.06. Average DT (ms) was 153.88 ms. 
Our study was valuable in describing the demographic profile, clinical 
presentation, anthropometric variability with increasing Grade of Diastolic 
dysfunction, risk factors & ECHO characteristics associated with increasing 
Grade of Diastolic dysfunction. 

STUDY LIMITATIONS 
This study & its results are limited by several important factors 
First and the most important factor is the sample size. Heart failure is a highly 
prevalent medical condition and it is essentially difficult to make & draw 
conclusions from the small sized (52 patients) study 
Secondly the study centre being a tertiary care centre, its patient population may 
include only severely ill and may not include mildly symptomatic patients, there 
by altering the prevalence and demographic characteristics. 
Third factor the definition of Heart Failure with Preserved Ejection Fraction 
‗HFNEF‘. Several of the recent studies accepted the criteria used in our study. 
But there are differences in opinion about the need for utilization of cardiac 
catheterization for the diagnosis of HFNEF. 
Fourth factor being, most the patients included in the study received treatment 
from different physicians and the treatment protocol was individualized. 
Presentation clinical profile would have had some impact due to these factors. 
 
 
 
 
  
 
 
 
CONCLUSIONS 
 
 
 
 
 
 
 
 
 
 
CONCLUSIONS 
The conclusions of this study are following: 
1) Patients with Heart failure with normal ejection fraction ‗HFNEF‘ are 
more likely to be older (75%) and women (57.69%). 
2) Dyspnea and fatigue (90.38%) are most common presenting symptoms 
3) Hypertension (94.23%) is the most common risk factor. 
4) Statistically significant association found with Hypertension (p=0.0195), 
Dyslipidemia (p=0.0447) & obesity (p=0.0437) with increasing Grade of 
diastolic dysfunction. 
5) Among the physical findings Fourth Heart sound (S4) is most commonly 
associated with increasing grade of Diastolic dysfunction, this association 
is extremely significant statistically (p<0.0001); also increasing BMI 
(p=0.036) & W/H ratio (p=0.012) are associated with increasing Grade of 
Diastolic dysfunction & this association was also statistically significant. 
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HEART FAILURE WITH PRESERVED EJECTION FRACTION      
CLINICAL PROFILE            RISKFACTOR ANALYSIS     & ECHO 
EVALUATION 
PROFORMA 
Name:                                                                                                  I.P.No.: 
Age: 
Sex:                                                                                                         DOA: 
Occupation: skilled.prof/semi-skilled.prof/manual labourer      DOD: 
Address: 
                                                                                      Socioeconomic status: 
Mobile No:                                                                              Schooling (yrs) - 
Diagnosis                                                                                           PHOTO 
Presenting Complaints 
Fatigue...........................................Yes/No 
Dyspnoea …............................…..Yes/No 
Pedal edema..................................Yes/No 
PND..............................................Yes/No 
Cheyne-Stokes breathing..............Yes/No 
Others--Anorexia /Nausea/Early satiety/Confusion/Sleep dist/Mood dist 
History of presenting illness 
Dyspnoea 
Duration - 
Onset                                             - sudden/insidious 
Time of onset in relation to pain   - 
Aggravating/precipitating factors - exertion/emotional upset/others 
Relieving factors                           - rest/posture/drugs 
NYHA Class                                 - I/II/III/IV   
 PND / orthopnoea/ platypnea / orthodeoxia 
Fatigue 
Duration - 
Onset                                             - sudden/insidious 
Aggravating/precipitating factors - exertion/emotional upset/others 
Relieving factors                           - rest/drugs 
Pedal edema 
Duration - 
Onset                                             - sudden/insidious 
Aggravating/precipitating factors - exertion/emotional upset/others 
Relieving factors                           - rest/drugs 
PERSONAL HISTORY 
Smoking                          - beedies/cigarettes 
                a) smoker 
                b) ex-smoker    -time since quit   ........ 
                c) Never smoker 
                                         - Duration  
                                         - number………/day 
                                         -pack yrs............ 
Alcohol                            - duration 
                                         - quantity……../day 
                                         - unit.............../week 
Tobacco chewing             - Yes/No 
                                         - Duration 
Treatment History  
- Any long term medication –       Yes/No        
                                                     - If yes mention Rx and duration of Rx 
GENERAL PHYSICAL EXAMINATION 
ANTHROPOMETRIC MEASUREMENTS 
Wt (in Kg) - 
Ht (in cm) - 
BMI (kg/m2) – 
Waist circumference – 
Hip circumference – 
Waist/Hip ratio – 
Icterus                              - Yes/No 
Pallor                                - Yes/No 
Cyanosis                           - central/Peripheral/Nil 
Clubbing                           - Yes/No 
Lymphadenopathy            - Yes/No 
Pedal edema                      - Yes/No 
Vitals: 
 Pulse                             -.............../ minute 
 BP                                 - ............../mmHg in right upper limb 
 Pulse pressure               - ............../mmHg 
CVS:  
Apical Impulse:  
Heart Sounds:  
Added sounds : S3 Y/N S4  Y/N 
Murmurs:  
RS : Air entry:  
Adventitious sounds:  
Per Abdomen :  
INVESTIGATIONS 
Hb                                        ........ gm% 
TLC                                     .........cells/cumm 
ESR                                    ...........mm/hour 
Urine routine                                   
RBS                                   ............mg% 
FBS, PPBS -                     .............mg% ..........mg% 
Serum creatinine              ............. mg% 
Urea                                  .............mg% 
Fasting lipid profile 
Total Cholesterol -            .............. mg% 
LDL -                               ............... mg% 
HDL -                              ................ mg% 
Triglycerides -                ................. mg% 
Chest x-ray                                                              USG abdomen & pelvis 
                    ECHOCARDIOGRAPHIC EVALUATION 
A) Ejection fraction 
B) E wave  
C) A wave  
D) E/A ratio 
E) DST (deceleration time) 
F) EDV 
G) GRADE OF DIASTOLIC DYSFUNCTION:  
MASTER CHART 
 
SNO AGE SEX FTG DYS EDE PND Y/NHGT WGT BMI BSA WST HIP W/H OBSALHSMKDBT DYL SHT MSYPR SBPDBPRR S3 S4 CRT E A E/A DT EF% LVEDVLVEDVIGRD
1 43 M Y Y Y N 169 88 30.81 1.98 105 100 1.1 Y Y Y N Y Y Y 88 230 130 20 N Y Y 1.2 0.8 1.5 120 53 93 46.96 3
2 47 M N Y Y N 172 98 33.12 2.1 112 123 0.9 Y N N Y N Y N 74 180 110 18 N Y N 1.2 1 1.2 155 51 98 46.66 2
3 60 M Y Y N N 168 86 30.47 1.95 89 91 1 Y Y Y Y N Y N 80 168 100 18 N N N 1.1 1 1.2 166 50 100 51.28 2
4 66 F Y Y Y Y 152 60 25.96 1.56 96 106 0.9 N N N Y Y Y Y 92 170 106 22 Y Y Y 1.1 1 1.1 154 55 94 60.25 2
5 85 F Y Y N N 148 53 24.19 1.45 82 94 0.9 N N N N N Y N 88 166 110 20 N N Y 0.7 1 0.7 210 56 88 60.68 1
6 56 F N Y N N 150 68 30.22 1.63 102 98 1 Y N N Y Y Y Y 75 160 100 20 Y Y Y 1 0.5 2.1 83 52 110 67.48 3
7 46 M N Y Y Y 173 102 34.08 2.15 123 134 0.9 Y Y Y N Y Y Y 102 148 94 22 Y Y Y 1 0.5 1.9 85 51 102 47.44 3
8 55 F Y Y N Y 148 58 26.47 1.51 82 94 0.9 N N N Y N Y Y 96 150 98 24 Y N Y 0.5 0.9 0.5 154 54 86 56.95 1
9 56 F Y Y Y Y 146 64 30.02 1.56 88 102 0.9 Y N N Y Y Y Y 98 148 108 23 Y N Y 1.2 1.1 1.1 160 48 118 75.64 2
10 60 F N Y N Y 147 74 34.24 1.66 98 106 0.9 Y N N Y Y Y Y 78 220 110 18 N Y Y 1.2 0.8 1.6 83 55 120 72.28 3
11 80 M Y Y N N 156 60 24.65 1.59 80 86 0.9 N Y Y N N Y N 82 150 98 18 Y N N 0.8 0.9 0.9 186 46 89 55.97 2
12 50 M N Y Y Y 174 108 35.67 2.21 112 110 1 Y Y Y Y Y Y Y 84 172 112 19 N N Y 0.5 0.9 0.6 156 52 121 54.75 1
13 62 F Y Y Y Y 150 60 26.66 1.54 92 104 0.9 N N N Y Y Y Y 88 152 92 22 Y N Y 0.6 0.9 0.8 140 48 98 63.63 1
14 50 F Y Y N N 165 81 29.75 1.88 97 102 1 N N N Y Y Y Y 86 156 92 23 N Y Y 1 1.1 0.9 160 50 89 47.34 2
15 63 F Y Y N Y 156 66 27.12 1.65 80 97 0.8 N N N Y Y N Y 78 134 84 18 N N N 0.7 1 0.7 158 46 106 64.24 1
16 60 F Y Y Y Y 152 70 30.29 1.66 96 101 1 Y N N Y Y N Y 92 132 80 20 Y N Y 0.5 0.7 0.8 166 52 102 61.44 1
17 88 F Y Y N N 146 53 24.86 1.43 83 76 1.1 N N N N N Y Y 78 158 110 18 Y Y Y 0.6 0.7 0.8 202 54 112 78.32 2
18 65 M Y Y Y Y 176 94 30.34 2.1 118 121 1 Y Y Y Y Y Y Y 80 178 118 23 Y Y Y 0.7 0.8 0.9 148 46 89 42.38 2
19 40 F Y Y Y N 144 66 31.82 1.56 88 94 0.9 Y N N Y Y Y Y 78 190 120 22 Y Y Y 1.1 0.9 1.3 154 50 110 70.51 2
20 70 F Y Y N Y 151 66 28.94 1.61 84 90 0.9 N N N Y N Y N 82 210 116 20 N Y N 0.9 1 0.9 178 48 86 53.41 2
21 56 F Y Y N N 158 70 28.04 1.71 92 96 1 N N N N N Y Y 86 200 124 20 N Y Y 1.2 0.9 1.4 142 52 79 46.19 2
22 46 M Y Y Y N 174 96 31.7 2.1 100 104 1 Y N N Y Y N Y 88 130 84 24 N N Y 0.7 1.1 0.6 123 56 96 45.71 1
23 76 M Y Y Y Y 178 98 30.93 2.15 110 106 1 Y N N N Y Y Y 92 198 120 24 Y Y Y 1.2 0.8 1.6 113 52 80 37.2 3
24 44 M Y N Y N 172 100 33.8 2.12 104 105 1 Y Y Y Y Y Y Y 88 150 86 20 Y N Y 0.7 1 0.7 146 48 111 52.35 1
25 50 M Y Y N Y 166 78 28.3 1.86 100 96 1 N N N N Y Y Y 92 210 118 22 N Y Y 1 0.6 1.9 80 55 98 52.68 3
26 54 M Y Y Y Y 156 58 23.83 1.56 90 91 1 N N N Y N N Y 90 130 84 20 Y N Y 0.6 0.9 0.6 166 52 116 74.35 1
27 55 M Y Y N Y 156 54 22.18 1.52 84 86 1 N Y Y Y N Y N 84 150 100 18 N N Y 1.2 1 1.2 170 51 98 64.47 2
28 46 M Y Y N Y 160 86 33.59 1.89 96 103 0.9 Y Y Y N Y Y Y 78 160 116 20 N Y Y 1.1 1 1.2 156 50 90 47.61 2
29 78 M Y Y N Y 150 46 20.44 1.38 84 81 1 N Y Y N N Y N 78 180 106 23 N N Y 0.6 0.9 0.6 188 54 88 63.76 1
30 48 M Y Y Y Y 176 98 31.63 2.14 103 105 1 Y Y Y Y Y Y Y 88 220 120 23 N Y Y 1.2 0.9 1.4 142 55 100 46.72 2
31 78 F Y Y N Y 148 46 21 1.36 78 82 1 N N N N N Y N 68 192 102 20 N Y Y 0.9 0.8 1.1 122 52 108 79.41 2
32 60 F Y Y Y N 152 66 28.56 1.62 92 96 1 N  N  N Y Y Y Y 76 168 118 22 N Y Y 1 0.8 1.3 156 50 100 61.72 2
33 81 F Y Y N N 156 60 24.65 1.59 84 88 1 N N N N Y Y Y 86 170 110 19 N Y N 0.5 0.8 0.7 168 51 76 47.79 1
34 80 M Y Y N N 154 52 21.92 1.48 84 88 1 N N N Y Y Y Y 74 186 112 18 N Y Y 0.7 0.9 0.7 198 52 89 60.13 1
35 76 F Y Y N N 148 60 27.39 1.53 86 93 0.9 N N N N Y Y Y 89 190 122 21 N Y Y 1.3 0.9 1.5 133 54 106 69.28 3
36 68 F Y Y N N 144 54 26.04 1.43 82 87 0.9 N N N N N Y N 92 164 98 22 N Y Y 1.1 0.9 1.2 167 53 121 84.61 2
37 70 F Y Y Y N 152 70 30.29 1.66 88 94 0.9 Y N N Y Y Y Y 88 172 112 22 N N Y 0.5 0.7 0.7 198 51 80 48.19 1
38 54 F Y Y Y Y 155 76 31.63 1.75 92 93 1 Y N N Y Y Y Y 87 196 122 25 Y Y Y 1.1 0.8 1.4 156 55 98 56 2
39 66 F Y Y N N 146 58 27.2 1.49 86 88 1 N N N Y Y Y Y 88 154 94 22 Y Y Y 0.9 1 0.9 162 50 86 57.71 2
40 88 F Y Y N N 142 48 23.8 1.35 82 80 1 N N N N N Y N 74 188 112 20 N Y Y 0.5 0.5 0.9 186 52 88 65.18 2
41 57 M Y Y Y N 166 78 28.3 1.86 92 90 1 N Y Y N Y Y Y 88 158 100 22 Y Y Y 0.9 1 0.9 168 50 98 52.68 2
42 65 F Y Y N N 148 66 30.13 1.59 88 92 1 Y N N Y Y Y Y 96 176 122 24 Y Y Y 1.6 1 1.6 128 54 112 70.44 3
43 76 F Y N Y Y 150 60 26.66 1.54 86 88 1 N N N N Y Y Y 78 150 110 20 N N Y 0.7 1 0.7 198 50 98 63.63 1
44 68 F Y Y N Y 146 56 26.27 1.47 86 90 1 N N N Y Y Y Y 68 166 116 22 N Y Y 0.9 1 0.9 178 50 84 57.14 2
45 88 F Y N N Y 156 66 27.12 1.65 76 80 1 N N N N N Y N 64 188 124 19 Y Y Y 0.3 0.5 0.6 180 54 68 41.21 1
46 49 F Y Y Y Y 152 70 30.29 1.66 92 93 1 Y N N Y Y Y Y 76 168 108 20 Y Y Y 1.2 1 1.3 176 52 86 51.8 2
47 66 F Y Y N Y 144 46 22.18 1.34 68 73 0.9 N N N N N Y N 68 200 112 22 N Y Y 1.1 1 1.1 176 55 112 83.58 2
48 73 M Y N N Y 160 56 21.87 1.57 78 83 0.9 N Y Y Y Y Y Y 76 140 96 20 Y N Y 0.7 1 0.7 178 53 196 124.8 1
49 76 F Y Y N N 143 49 23.96 1.37 79 84 0.9 N N N Y N Y Y 78 156 100 22 N N Y 0.4 0.8 0.6 120 50 76 55.47 1
50 56 M Y N N Y 158 60 24.03 1.6 86 88 1 N Y Y N Y Y Y 88 188 112 23 N Y Y 1 0.7 1.4 164 52 108 67.5 2
51 43 M Y Y N Y 163 84 31.61 1.89 97 102 1 Y Y Y Y Y Y Y 74 190 108 24 N Y Y 0.6 1 0.6 156 51 110 58.2 1
52 59 M Y Y Y Y 173 110 36.75 2.22 124 132 0.9 Y Y Y Y Y Y Y 88 220 124 26 Y Y Y 1.5 0.7 2.1 90 55 120 54.05 3
KEYS TO MASTER CHART 
FTG                                     Fatigue 
DYS                                     Dyspnea 
EDE                                     Edema 
PND                                     Paroxysmal Nocturnal Dyspnea 
HGT                                     Height 
WGT                                    Weight 
BMI                                      Body Mass Index 
BSA                                      Body Surface Area 
WST                                     Waist Circumference 
HIP                                       Hip Circumference 
W/H                                     Waist-Hip Ratio 
OBS                                     Obesity 
ALH                                     Alcohol 
SMK                                    Smoking 
DM                                       Diabetes mellitus 
DYL                                     Dyslipidemia 
SHT                                      Hypertension 
MSY                                     Metabolic Syndrome 
PR                                           Pulse rate  
SBP                                         Systolic Blood Pressure 
DBP                                        Diastolic Blood Pressure  
RR                                          Respiratory Rate 
S3                                           Third Heart Sound 
S4                                           Fourth Heart Sound 
CRS                                        Crepts                                         
E                                             E Wave Velocity 
A                                             A Wave Velocity 
E/A                                         E/A Ratio 
DT                                          Deceleration Time 
EF                                           Ejection Fraction 
LVEDV                                   Left Ventricular End-Diastolic Volume  
LVEDVI                                  Left Ventricular End-Diastolic Volume Index 
GRD                                        Grade Of Diastolic Dysfunction 
ABBREVIATIONS 
HF                                             Heart Failure 
LV                                            Left Ventricle 
LA                                            Left Atrium 
LVEF                                       Left Ventricular Ejection Fraction 
SHF                                         Systolic Heart Failure 
DHF                                        Diastolic Heart Failure 
HFNEF                                   Heart Failure with Normal Ejection Fraction 
HFpEF                                      Heart Failure with Preserved Ejection Fraction 
ECHO                                      Echocardiogram 
EF                                            Ejection Fraction 
DD                                           Diastolic Dysfunction 
HCM                                       Hypertrophic Cardiomyopathy 
LVH                                        Left Ventricular Hypertrophy 
ECG                                        Electrocardiogram 
ICU                                         Intensive Care Unit 
MVO                                      Mitral Valve Orifice 
AR                                          Atrial Retrograde Velocity 
S/D                    ratio of systolic to diastolic velocity of venous pulmonary veins 
TDI                                       Tissue Doppler Imaging 
IVR                                        Isovolumic Relaxation 
IVRT                                     Isovolumic Relaxation Time 
PND                                      Paroxysmal Nocturnal Dyspnea 
NYHA                                  New York Heart Association 
CABG                                  Coronary Artery Bypass Grafting 
CKD                                     Chronic Kidney Disease 
CHF                                      Congestive Heart Failure 
 
